Skip to main content
. 2018 Mar 1;123(1):19–27. doi: 10.1080/03009734.2018.1440037

Table 2.

Clinical characteristics of 79 AML patients for the detection of miR-130a.

Cytogenetic group Number of cases (%) Gender (M/F) Median age (year) Median WBC (×109/L) Median blasts (%)
t(8;21) 32 21/11 29.5 16.6 58
inv(16) 11 5/6 31 68.8 51
t(15;17) 6 3/3 34 24.3 80
Rearrangements  involving MLL 13 4/9 37 13.96 75
Other abnormalities 10 5/5 56 92.25 69.25
Normal karyotype 7 3/4 35 31.4 91.4